SEC Form 4 · accession 0001144204-15-034803
PALISADE BIO, INC. · PALI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Clyde Oldaker
Director
Period of report
May 27, 2015
Accepted (ET)
Jun 1, 2015 · 4:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001357459
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 27, 2015 | M | 60,000 | $1.32 | A | 176,939 | D | |
| Common StockF1 | May 27, 2015 | F | 48,589 | $1.63 | D | 128,350 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock purchase optionF2 | $1.32 | May 27, 2015 | M | 60,000 | D | May 28, 2008 | May 28, 2008 | Common Stock | 60,000 | 0 | D |
Explanation of responses
- F1Represents 48,589 shares withheld by the Issuer at the market price of $1.63 per share less an exercise price of $1.32 per share to fund the cashless exercise of 60,000 options. The total number of shares issued to Reporting Person pursuant to the cashless exercise of the options is 11,411.
- F2Represents option issued pursuant to Issuer's 2007 Equity Compensation Plan and in compliance with its non-executive director compensation plan. The option was exercised on a cashless basis on 5/27/2015.